| 000 | 01881 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516070317.0 | ||
| 264 | 0 | _c20120402 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a2040-2058 | ||
| 024 | 7 |
_a10.3851/IMP1896 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharpentier, Charlotte | |
| 245 | 0 | 0 |
_aSurveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic. _h[electronic resource] |
| 260 |
_bAntiviral therapy _c2011 |
||
| 300 |
_a1347-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCentral African Republic _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDNA Fingerprinting |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdiagnosis |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNevirapine _xadministration & dosage |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
| 700 | 1 | _aGody, Jean-Chrysostome | |
| 700 | 1 | _aTisserand, Pascaline | |
| 700 | 1 | _aMatta, Mathieu | |
| 700 | 1 | _aPéré, Hélène | |
| 700 | 1 | _aFournier, Julien | |
| 700 | 1 | _aMbitikon, Olivia | |
| 700 | 1 | _aBélec, Laurent | |
| 773 | 0 |
_tAntiviral therapy _gvol. 16 _gno. 8 _gp. 1347-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3851/IMP1896 _zAvailable from publisher's website |
| 999 |
_c21379131 _d21379131 |
||